Total Payments
$1,182
2024 Payments
$23.75
Companies
12
Transactions
77
Medicare Patients
3,995
Medicare Billing
$321,929
Payment Breakdown by Category
Food & Beverage$1,162 (98.4%)
Gifts$19.40 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,162 | 68 | 98.4% |
| Gift | $19.40 | 1 | 1.6% |
| Unspecified | $0 | 8 | 0.0% |
Payments by Type
General
$1,182
69 transactions
Ownership
$0
8 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $840.87 | 59 | $0 (2019) |
| Horizon Therapeutics plc | $120.00 | 1 | $0 (2022) |
| Carl Zeiss Meditec, Inc. | $43.53 | 1 | $0 (2018) |
| TISSUETECH, INC. | $36.67 | 1 | $0 (2021) |
| BioTissue Holdings, Inc. | $30.36 | 1 | $0 (2022) |
| Tarsus Pharmaceuticals, Inc. | $23.75 | 1 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $21.52 | 1 | $0 (2020) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $19.92 | 1 | $0 (2020) |
| Carl Zeiss Meditec AG | $19.40 | 1 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $13.19 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23.75 | 2 | Tarsus Pharmaceuticals, Inc. ($23.75) |
| 2023 | $0 | 1 | Spinal Surgical Strategies, Inc. |
| 2022 | $150.36 | 3 | Horizon Therapeutics plc ($120.00) |
| 2021 | $36.67 | 2 | TISSUETECH, INC. ($36.67) |
| 2020 | $60.84 | 4 | Sun Pharmaceutical Industries Inc. ($21.52) |
| 2019 | $303.89 | 22 | Allergan Inc. ($303.89) |
| 2018 | $564.21 | 39 | Allergan Inc. ($520.68) |
| 2017 | $42.07 | 4 | Allergan Inc. ($16.30) |
All Payment Transactions
77 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/28/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 2024 | Spinal Surgical Strategies, Inc. | — | — | — | $0.00 | Ownership |
| 2023 | Spinal Surgical Strategies, Inc. | — | — | — | $0.00 | Ownership |
| 10/12/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: TEPEZZA | ||||||
| 02/15/2022 | BioTissue Holdings, Inc. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $30.36 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 2022 | Spinal Surgical Strategies, Inc. | — | — | — | $0.00 | Ownership |
| 06/30/2021 | TISSUETECH, INC. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $36.67 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 2021 | Spinal Surgical Strategies, Inc. | — | — | — | $0.00 | Ownership |
| 04/22/2020 | Carl Zeiss Meditec AG | None Specified (Medical Supply) | Gift | In-kind items and services | $19.40 | General |
| 03/25/2020 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/09/2020 | Sun Pharmaceutical Industries Inc. | CEQUA (Drug) | Food and Beverage | Cash or cash equivalent | $21.52 | General |
| Category: Ophthalmology | ||||||
| 2020 | Spinal Surgical Strategies, Inc. | — | — | — | $0.00 | Ownership |
| 12/09/2019 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/25/2019 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/25/2019 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $1.58 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/15/2019 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $4.21 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/05/2019 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $4.41 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/23/2019 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $9.91 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/05/2019 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $4.80 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/26/2019 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $9.93 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/16/2019 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $9.40 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/30/2019 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/25/2019 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $4.64 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/18/2019 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/03/2019 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 984 | 1,025 | $203,010 | $79,811 |
| 2022 | 8 | 968 | 1,032 | $201,860 | $77,381 |
| 2021 | 8 | 1,048 | 1,126 | $211,010 | $87,085 |
| 2020 | 10 | 995 | 1,068 | $190,550 | $77,652 |
Total Patients
3,995
Total Services
4,251
Medicare Billing
$321,929
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 454 | 466 | $105,840 | $47,349 | 44.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 146 | 164 | $32,800 | $12,477 | 38.0% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 60 | 60 | $18,000 | $7,278 | 40.4% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 94 | 99 | $15,840 | $5,048 | 31.9% |
| 92133 | Imaging of optic nerve | Office | 2023 | 156 | 160 | $20,800 | $4,923 | 23.7% |
| 92134 | Imaging of retina | Office | 2023 | 38 | 39 | $5,070 | $1,318 | 26.0% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 16 | 16 | $2,560 | $1,025 | 40.0% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 20 | 21 | $2,100 | $392.02 | 18.7% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 424 | 444 | $97,680 | $43,890 | 44.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 161 | 186 | $37,200 | $13,713 | 36.9% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 71 | 71 | $21,300 | $7,674 | 36.0% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 93 | 101 | $16,160 | $4,923 | 30.5% |
| 92133 | Imaging of optic nerve | Office | 2022 | 148 | 156 | $20,280 | $4,778 | 23.6% |
| 92134 | Imaging of retina | Office | 2022 | 30 | 32 | $4,160 | $1,098 | 26.4% |
| 92002 | New patient problem focused exam of visual system | Office | 2022 | 14 | 14 | $2,280 | $801.30 | 35.1% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2022 | 27 | 28 | $2,800 | $504.63 | 18.0% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 459 | 473 | $104,060 | $49,569 | 47.6% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 176 | 207 | $36,100 | $16,480 | 45.7% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 58 | 58 | $17,400 | $7,314 | 42.0% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 100 | 117 | $18,720 | $5,737 | 30.6% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 178 | 194 | $25,220 | $5,719 | 22.7% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 42 | 42 | $5,460 | $1,495 | 27.4% |
| 92201 | Extended examination of eye with drawing of retina | Office | 2021 | 24 | 24 | $2,400 | $522.72 | 21.8% |
| 92250 | Photography of the retina | Office | 2021 | 11 | 11 | $1,650 | $247.12 | 15.0% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 375 | 389 | $85,660 | $39,275 | 45.8% |
About Dr. Bruce Kirschner, M.D
Dr. Bruce Kirschner, M.D is a Ophthalmology healthcare provider based in Burlingame, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972699015.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Kirschner, M.D has received a total of $1,182 in payments from pharmaceutical and medical device companies, with $23.75 received in 2024. These payments were reported across 77 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,162).
As a Medicare-enrolled provider, Kirschner has provided services to 3,995 Medicare beneficiaries, totaling 4,251 services with total Medicare billing of $321,929. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Burlingame, CA
- Active Since 10/05/2006
- Last Updated 07/08/2007
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1972699015
Products in Payments
- LUMIGAN (Drug) $527.89
- RESTASIS (Drug) $263.05
- TEPEZZA (Drug) $120.00
- PROKERA (Device) $67.03
- FORUM (Device) $43.53
- XDEMVY (Drug) $23.75
- CEQUA (Drug) $21.52
- VYZULTA (Drug) $19.92
- None Specified (Medical Supply) $19.40
- PAZEO (Drug) $13.19
- XIIDRA (Drug) $12.58
- ALPHAGAN P (Drug) $7.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Burlingame
Edward Koo, M.d, M.D
Ophthalmology — Payments: $957,101
Ophthalmology $957,101
Kenneth Chern, M.d, M.D
Ophthalmology — Payments: $43,380
Ophthalmology $43,380
Kim Cooper, Md, MD
Ophthalmology — Payments: $3,196
Ophthalmology $3,196
Alden Bahr
Ophthalmology — Payments: $853.15
Ophthalmology $853.15
Dr. Robert Elliston, M.d, M.D
Ophthalmology — Payments: $206.78
Ophthalmology $206.78
Dr. Rupali Apte, M.d, M.D
Ophthalmology — Payments: $55.03
Ophthalmology $55.03